Sinopharm: Net profit of 137 million yuan in 2025, compared to a loss of 25.8755 million yuan in the same period last year.

Sundai Corporation announced that in 2025, its operating income was 2.36 billion yuan, a decrease of 2.43% year-on-year; net profit was 137 million yuan, a turnaround from a loss of 25.8755 million yuan in the same period last year. Through measures such as deepening channel reform, accelerating the industrialization of innovative products, and promoting cost reduction and efficiency improvement in the production system, the company successfully turned losses into profits and significantly improved its operating performance.